CareDx Leads Transplant Innovation with AiKidney, an AI Clinical Decision Support Tool for Predicting Allograft Rejection Risk
This follows CareDxs recently announced plans to add an artificial intelligence (AI) prognostic for cardiac allograft vasculopathy (CAV).
- This follows CareDxs recently announced plans to add an artificial intelligence (AI) prognostic for cardiac allograft vasculopathy (CAV).
- AiKidney can be used for informing clinical management decisions and to help clinicians predict the long-term impact of treatments.
- This ongoing partnership is yielding positive results and it is exciting to see AiKidney coming to fruition in the clinic.
- AiKidney supports this assessment by providing information about a patients risk of allograft rejection and expected long-term graft survival.